Swipe om te navigeren naar een ander artikel
This study aimed to investigate the psychometric properties of the Fatigue Severity Scale (FSS), a widely used unidimensional fatigue measure, in patients with major depression.
Subjects included were 72 patients with major depressive disorder, diagnosed with the DSM-IV based M.I.N.I. 5.0.0., without comorbid fatigue-associated conditions and Hamilton Depression Rating Scale (HDRS) scores ≥ 17 as well as 40 sex- and age-matched healthy controls. The FSS was administered to patients on two time points separated by a 1-week interval and to controls. The vitality subscale of the 36-item Short Form Health Survey (SF-36vit) and a visual analogue fatigue scale (VASF) were also administered.
A total of 79.2% of patients vs. 15% of controls were fatigue cases according to the M.I.N.I. fatigue/energy loss item. The distribution of FSS scores was negatively skewed in the patient group, demonstrating a ceiling effect. The FSS presented satisfactory test–retest reliability (intraclass correlation coefficient 0.993), internal consistency (Cronbach’s α coefficient 0.947), concurrent validity (correlations with SF-36vit, VASF and HDRS were −0.52, 0.73 and 0.32, respectively) and discriminative validity between patients and controls. Factor analysis demonstrated a unidimensional structure. The optimal FSS cutoff score for clinically significant fatigue was 5.4 against the presence of fatigue/energy loss according to the M.I.N.I. as a ‘gold standard’.
When administered to patients with major depression, the FSS was shown to have satisfactory psychometric properties with the exception of a ceiling effect, which may pose limitations to its use in this population.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Pawlikowska, T., Chalder, T., Hirsch, S. R., et al. (1994). Population based study of fatigue and psychological distress. British Medical Journal,308, 763–766. PubMed
Maurice-Tison, S., Verdoux, H., Gay, B., et al. (1998). How to improve recognition and diagnosis of depressive syndromes using international diagnostic criteria. British Journal of General Practice,48, 1245–1246. PubMed
Tylee, A., Gastpar, M., Lepine, J. P., & Mendlewicz, J. (1999). DEPRES II (Depression Research in European Society II): A patient survey of the symptoms, disability and current management of depression in the community. International Clinical Psychopharmacology,14, 139–151. PubMed
Stahl, S. M., Zhang, L., Damatarca, C., & Grady, M. (2003). Brain circuits determine destiny in depression: A novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder. Journal of Clinical Psychiatry,64(Suppl 14), 6–17.
Krupp, L. B., LaRocca, N. G., Muir-Nash, J., & Steinberg, A. D. (1989). The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of Neurology,46, 1121–1123. PubMed
Merkies, I. S., Schmitz, P. I., Samijn, J. P., van der Meche, F. G., & van Doorn, P. A. (1999). Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Neurology,53, 1648–1654. PubMed
Abe, K., Takanashi, M., & Yanagihara, T. (2000). Fatigue in patients with Parkinson’s disease. Behavioural Neurology,12, 103–106. PubMed
Friedberg, F., & Krupp, L. B. (1994). A comparison of cognitive behavioral treatment for chronic fatigue syndrome and primary depression. Clinical Infectious Diseases,18, S105–S110. PubMed
Pepper, C. M., Krupp, L. B., Friedberg, F., Doscher, C., & Coyle, P. K. (1993). A comparison of neuropsychiatric characteristics in chronic fatigue syndrome, multiple sclerosis, and major depression. Journal of Neuropsychiatry and Clinical Neurosciences,5, 200–205. PubMed
DeBattista, C., Doghramji, K., Menza, M. A., Rosenthal, M. H., & Fieve, R. R. (2003). Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: A preliminary double-blind, placebo-controlled study. Journal of Clinical Psychiatry,64, 1057–1064. PubMedCrossRef
Ninan, P. T., Hassman, H. A., Glass, S. J., & McManus, F. C. (2004). Adjunctive modafinil at initiation of treatment with a selective serotonin reuptake inhibitor enhances the degree and onset of therapeutic effects in patients with major depressive disorder and fatigue. Journal of Clinical Psychiatry,65, 414–420. PubMedCrossRef
Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., et al. (1998). The mini-international neuropsychiatric interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry,59(Suppl 20), 22–33. PubMed
Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry,23, 56–62. CrossRef
Sartorius, N., & Janca, A. (1996). Psychiatric assessment instruments developed by the world health organization. In G. Thornicroft & M. Tansella (Eds.), Mental health outcome measures (pp. 153–177). Berlin: Springer.
Ware, J. E., Snow, K. K., Kosinki, M., & Gandek, B. (1993). SF-36 health survey: Manual and interpretation guide. Boston, MA: The Health Institute.
McGraw, K. O., & Wong, S. P. (1996). Forming inferences about some intraclass correlation coefficients. Psychological Methods,1, 30–46. CrossRef
Altman, D. G. (1996). Inter-rater agreement in practical statistics for medical research. London, UK: Chapman & Hall.
Winstead-Fry, P. (1998). Psychometric assessment of four fatigue scales with a sample of rural cancer patients. Journal of Nursing Measurement,6, 111–122. PubMed
MacCallum, R. C., Widaman, K. F., Zhang, S., & Hong, S. (1999). Sample size in factor analysis. Psychological Methods,4, 84–99. CrossRef
Bryant, F. B., & Yarnold, P. R. (1995). Principal components analysis and exploratory and confirmatory factor analysis. In L. G. Grimm & R. R. Yarnold (Eds.), Reading and understanding multivariale statistics (pp. 99–136). Washington, DC: American Psychological Association.
Roelcke, U., Kappos, L., Lechner-Scott, J., et al. (1997). Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: A 18F-fluorodeoxyglucose positron emission tomography study. Neurology,48, 1566–1571. PubMed
Bakshi, R., Miletich, R. S., Henschel, K., et al. (1999). Fatigue in multiple sclerosis: Cross-sectional correlation with brain MRI findings in 71 patients. Neurology,53, 1151–1153. PubMed
Ferentinos, P., Kontaxakis, V., Havaki-Kontaxaki, B., et al. (2009). Sleep disturbances in relation to fatigue in major depression. Journal of Psychosomatic Research,66, 37–42. PubMed
Papakostas, G. I. (2008). Tolerability of modern antidepressants. Journal of Clinical Psychiatry,69(Suppl E1), 8–13. PubMed
- Psychometric evaluation of the Fatigue Severity Scale in patients with major depression
- Springer Netherlands